nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis
|
You, Hong |
|
|
16 |
1 |
p. 1-23 |
artikel |
2 |
A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes
|
Wan, Sizhe |
|
|
16 |
1 |
p. 112-124 |
artikel |
3 |
Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers
|
Kikuchi, Minami |
|
|
16 |
1 |
p. 68-80 |
artikel |
4 |
Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review
|
Zou, Huimin |
|
|
16 |
1 |
p. 27-37 |
artikel |
5 |
Establishment and validation of a prognostic model for hepatitis B virus‑related acute-on-chronic liver failure patients with bacterial infection
|
Zhang, Zhongwei |
|
|
16 |
1 |
p. 38-47 |
artikel |
6 |
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial
|
Chen, Wei-Ting |
|
|
16 |
1 |
p. 148-158 |
artikel |
7 |
Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer
|
Deng, Tuo |
|
|
16 |
1 |
p. 99-111 |
artikel |
8 |
Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure
|
Thanapirom, Kessarin |
|
|
16 |
1 |
p. 171-182 |
artikel |
9 |
Iodized oil CT-guided radiofrequency ablation for hepatocellular carcinoma within Milan criteria
|
Duan, Lei |
|
|
16 |
1 |
p. 207-208 |
artikel |
10 |
Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria
|
Jindal, Ankur |
|
|
16 |
1 |
p. 89-98 |
artikel |
11 |
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study
|
Mak, Lung-Yi |
|
|
16 |
1 |
p. 48-58 |
artikel |
12 |
Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies
|
Illiano, M. |
|
|
16 |
1 |
p. 125-134 |
artikel |
13 |
Non-alcoholic fatty liver disease frequency and associated factors at admission of acute stroke
|
Mori, Takahisa |
|
|
16 |
1 |
p. 81-88 |
artikel |
14 |
Non-alcoholic fatty liver disease in cerebrovascular disease: a bystander or a real risk factor?
|
Mak, Lung-Yi |
|
|
16 |
1 |
p. 24-26 |
artikel |
15 |
Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period
|
Kaibori, Masaki |
|
|
16 |
1 |
p. 135-147 |
artikel |
16 |
Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative study
|
Shiha, Gamal |
|
|
16 |
1 |
p. 159-170 |
artikel |
17 |
Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China
|
Mei, Xue |
|
|
16 |
1 |
p. 183-194 |
artikel |
18 |
Reciprocal alterations in circulating and hepatic gamma–delta T cells in patients with primary biliary cholangitis
|
Chen, Sha |
|
|
16 |
1 |
p. 195-206 |
artikel |
19 |
Response to “Iodized Oil CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Within Milan Criteria”
|
Wu, Chih-Horng |
|
|
16 |
1 |
p. 209-210 |
artikel |
20 |
Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)
|
Huang, Jee-Fu |
|
|
16 |
1 |
p. 59-67 |
artikel |